Published in Am J Surg Pathol on August 01, 2009
Stereotactic body radiation therapy in the re-irradiation situation--a review. Radiat Oncol (2013) 1.08
Mesothelial cell clusters in endometrial biopsy: another possible source of diagnostic pitfall. Am J Surg Pathol (2010) 0.75
Ovarian cancer progression is controlled by phenotypic changes in dendritic cells. J Exp Med (2012) 2.85
Implications of LINE1 methylation for bladder cancer risk in women. Clin Cancer Res (2010) 2.10
Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking and bladder cancer susceptibility. Carcinogenesis (2005) 2.08
Clinical and immunologic effects of intranodal autologous tumor lysate-dendritic cell vaccine with Aldesleukin (Interleukin 2) and IFN-{alpha}2a therapy in metastatic renal cell carcinoma patients. Clin Cancer Res (2009) 1.94
Ureteroscopic biopsy of upper tract urothelial carcinoma using a novel ureteroscopic biopsy forceps. Can J Urol (2012) 1.46
Bladder cancer SNP panel predicts susceptibility and survival. Hum Genet (2009) 1.43
Epigenetic inactivation of SFRP genes and TP53 alteration act jointly as markers of invasive bladder cancer. Cancer Res (2005) 1.40
Promoter hypermethylation is associated with current smoking, age, gender and survival in bladder cancer. Carcinogenesis (2007) 1.40
Electrical impedance spectroscopy of the human prostate. IEEE Trans Biomed Eng (2007) 1.39
Chemokine receptor expression in the human ectocervix: implications for infection by the human immunodeficiency virus-type I. Immunology (2004) 1.38
Microsatellite instability at tetranucleotide repeats in skin and bladder cancer. Oncogene (2002) 1.33
Identification of methylated genes associated with aggressive bladder cancer. PLoS One (2010) 1.27
The diaphragms of fenestrated endothelia: gatekeepers of vascular permeability and blood composition. Dev Cell (2012) 1.13
Occupation and bladder cancer risk in a population-based case-control study in New Hampshire. Cancer Causes Control (2004) 1.06
Recurrent perivascular epithelioid cell tumor of the uterus (PEComa): an immunohistochemical study and review of the literature. Gynecol Oncol (2003) 0.97
Correlation of LINE-1 methylation levels in patient-matched buffy coat, serum, buccal cell, and bladder tumor tissue DNA samples. Cancer Epidemiol Biomarkers Prev (2012) 0.94
Developing a rational tumor vaccine therapy for renal cell carcinoma: immune yin and yang. Clin Cancer Res (2007) 0.93
Bladder cancer risk and personal hair dye use. Int J Cancer (2004) 0.92
EGFR pathway polymorphisms and bladder cancer susceptibility and prognosis. Carcinogenesis (2009) 0.92
Distinct mechanisms of action of anti-CD154 in early versus late treatment of murine lupus nephritis. Arthritis Rheum (2003) 0.90
Body mass and smoking are modifiable risk factors for recurrent bladder cancer. Cancer (2013) 0.90
Association of secondhand smoke exposures with DNA methylation in bladder carcinomas. Cancer Causes Control (2011) 0.90
Scrotal lymphangioma: an uncommon cause for a scrotal mass. J Ultrasound Med (2002) 0.90
Genetic variant as a selection marker for anti-prostate stem cell antigen immunotherapy of bladder cancer. J Natl Cancer Inst (2012) 0.88
HSD3B and gene-gene interactions in a pathway-based analysis of genetic susceptibility to bladder cancer. PLoS One (2012) 0.88
DNA repair genotype interacts with arsenic exposure to increase bladder cancer risk. Toxicol Lett (2009) 0.86
Priapism in a 15-year-old boy with congenital dyserythropoietic anemia type II (hereditary erythroblastic multinuclearity with positive acidified serum lysis test). J Urol (2002) 0.84
Impaired cytolytic activity in peripheral blood T cells from renal cell carcinoma patients. Clin Immunol (2005) 0.84
Arsenic exposure predicts bladder cancer survival in a US population. World J Urol (2009) 0.83
Passive bioelectrical properties for assessing high- and low-grade prostate adenocarcinoma. Prostate (2011) 0.83
Tumor-related immunity in prostate cancer patients treated with human recombinant granulocyte monocyte-colony stimulating factor (GM-CSF). Prostate (2006) 0.83
Cell-cycle control in urothelial carcinoma: large-scale tissue array analysis of tumor tissue from Maine and Vermont. Cancer Epidemiol Biomarkers Prev (2012) 0.82
Intake of α-linolenic acid and other fatty acids in relation to the risk of bladder cancer: results from the New Hampshire case-control study. Br J Nutr (2011) 0.81
Functional disability and compromised mobility among older women with urinary incontinence. Female Pelvic Med Reconstr Surg (2015) 0.81
Quality improvement by standardization of procurement and processing of thyroid fine-needle aspirates in the absence of on-site cytological evaluation. Thyroid (2009) 0.80
Implementation of telecytology for immediate assessment of endoscopic ultrasound-guided fine-needle aspirations compared to conventional on-site evaluation: analysis of 240 consecutive cases. Acta Cytol (2012) 0.80
Genetic polymorphisms modify bladder cancer recurrence and survival in a USA population-based prognostic study. BJU Int (2014) 0.80
Intraperitoneal India ink deposits appearing as endometriosis in a patient with chronic pelvic pain. Obstet Gynecol (2008) 0.80
Immunohistochemical patterns of ProEx C in vulvar squamous lesions: detection of overexpression of MCM2 and TOP2A. Am J Surg Pathol (2010) 0.76
Immunological effects of granulocyte-macrophage colony-stimulating factor and autologous tumor vaccine in patients with renal cell carcinoma. J Urol (2004) 0.76
Prostate Cancer Detection Using Composite Impedance Metric. IEEE Trans Med Imaging (2016) 0.75
Clerkship enhancement of interpersonal skills. Am J Surg (2005) 0.75
Best cases from the AFIP: testicular seminoma with lymph node metastases. Radiographics (2009) 0.75
Does pelvic organ prolapse reduction affect abdominal leak point pressures? J Reprod Med (2008) 0.75
Comparative study of separation between ex-vivo prostatic malignant and benign tissue using electrical impedance spectroscopy and electrical impedance tomography. Physiol Meas (2017) 0.75
Polyomavirus infection of the urinary tract presenting as hemorrhagic cystitis in an immunocompetent five-year-old boy. Diagn Cytopathol (2008) 0.75
Gliomatosis peritonei and teratomatous implant with carcinomatous transformation presenting 54 years following oophorectomy for dermoid cyst. Gynecol Oncol (2004) 0.75
Stromal lipofuscinosis of the seminal vesicle. Pathology (2010) 0.75
Ovarian strumal carcinoid producing peptide YY associated with severe constipation: a case report and review of the literature. Int J Gynecol Pathol (2015) 0.75
Real-time polymerase chain reaction and laser capture microdissection for the diagnosis of BK virus infection in renal allografts. Am J Clin Pathol (2005) 0.75
Urodynamic leak point pressures weakly correlate with subjective urinary incontinence severity. Int J Gynaecol Obstet (2008) 0.75